Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
1.240
-0.020 (-1.59%)
Nov 20, 2026, 3:00 PM CST
Kangmei Pharmaceutical Market Cap
Kangmei Pharmaceutical has a market cap or net worth of 17.15 billion as of November 20, 2026. It is the 5,349th most valuable company in the world and the 828th biggest in China. Its market cap has decreased by 39.22% in one year.
Market Cap
17.15B
Enterprise Value
15.97B
Revenue
4.82B
Global Rank
Country Rank
#828 China
PE Ratio
204.52
ChartMarket Cap Chart
Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 17.15B, an increase of 565.02%. That is a compound annual growth rate of 7.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 17.15B | -35.08% |
| Dec 31, 2025 | 26.41B | -18.58% |
| Dec 31, 2024 | 32.44B | 25.81% |
| Dec 29, 2023 | 25.79B | -15.45% |
| Dec 30, 2022 | 30.50B | -28.80% |
| Dec 31, 2021 | 42.84B | 221.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chengdu Kanghong Pharmaceutical Group | 20.29B |
| Guangdong Zhongsheng Pharmaceutical | 20.28B |
| Jilin Aodong Pharmaceutical Group | 19.68B |
| Shanghai Haoyuan Chemexpress | 19.36B |
| Joincare Pharmaceutical Group Industry | 19.26B |
| Hybio Pharmaceutical | 18.98B |
| Betta Pharmaceuticals | 18.12B |
| Walvax Biotechnology | 16.92B |